2 Stocks to Buy Near Their 52-Week Lows
When a downturn hits, even industry leaders feel the pressure. That's been the case for two companies in particular: telehealth specialist Teladoc Health (NYSE: TDOC) and animal health company Zoetis (NYSE: ZTS). These corporations are among the most prominent players in their respective markets, but that hasn't stopped investors from selling off their shares this year.
Thankfully, both companies have plenty of opportunities that could pay off for patient investors. Let's consider why Zoetis and Teladoc are worth buying while they are still hovering near their 52-week lows.
Source Fool.com



